Carregant...
Discovery of a novel inhibitor of kinesin-like protein KIFC1*
Historically, drugs used in the treatment of cancers also tend to cause damage to healthy cells while affecting cancer cells. Therefore, the identification of novel agents that act specifically against cancer cells remains a high priority in the search for new therapies. In contrast to normal cells,...
Guardat en:
| Publicat a: | Biochem J |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5488687/ https://ncbi.nlm.nih.gov/pubmed/26846349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20150992 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|